Skip to content

Tonix Pharmaceuticals Logo

  • About
    • Leadership
      • Executive Team
      • Board of Directors
    • Facilities
  • Therapeutic Areas Overview
    • Central Nervous System
      • Fibromyalgia
      • Migraine
    • Infectious Disease
      • Lyme Disease
      • Mpox (Monkey Pox)
      • Smallpox
    • Immunology and Immuno-oncology
      • Organ Transplant Rejection
      • Gastro-Intestinal Cancers
    • Rare Disease
      • Prader-Willi Syndrome
  • Pipeline
    • Central Nervous System
      • TNX-102 SL
      • TNX-1300
    • Infectious Disease
      • TNX-4800
      • TNX-801
      • TNX-4200
    • Immunology and Immuno-oncology
      • TNX-1500
      • TNX-1700
      • TNX-4700
    • Rare Disease
      • TNX-2900
    • Expanded Access Policy
  • Medicines
  • Clinical
    • Clinical Trials
    • Adverse Event Reporting
    • Submit a Grant Proposal
    • Submit a Research Proposal
    • Pain Guides
      • Fibromyalgia Pain Guide
      • Migraine Pain Guide
  • News & Events
    • Press Releases
    • Investor Presentations
    • Scientific Presentations
    • IR Events
    • Op-eds
  • Investors
    • News & Events
    • Presentations
      • Investor Presentations
      • Scientific Presentations
      • Program Specific Presentations
      • Conference Materials
    • Multimedia
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact Us
November 2022

In Vitro Impact of Oxytocin on Human Sensory Neurons

September 2022

Retrospective Observational Database Study of Patients with Long COVID with Multi-Site Pain, Fatigue, and Insomnia: A Real-World Analysis of Symptomatology and Opioid Use

September 2022

Monotherapy with TNX-1500, an Fc-modified Anti-CD154 mAb, Prolongs Cardiac Allograft Survival in Cynomolgus Monkeys

September 2022

Long-term (>1 year) Rejection/TMA Free Survival of Kidney Xenografts with Triple Xenoantigen Knockout and Multiple Human Transgenes in Nonhuman Primates

September 2022

Long-term Rejection Free Renal Allograft Survival with Fc-modified Anti-CD154 Antibody Monotherapy in Nonhuman Primates

June 2022

TNX-1500, an Fc-modified Anti-CD154 Antibody, Prolongs Nonhuman Primate Cardiac Allograft Survival 

June 2022

Long Term Rejection Free Renal Allograft Survival with Fc Modified Anti CD154 Antibody Monotherapy in Nonhuman Primates

June 2022

Novel Targetable Pathways in Costimulation Pathway Blockade

June 2022

The Virus-host Interface: A Treasure Trove of Novel Antiviral Targets

June 2022

Synthetic Chimeric Horsepox Virus (scHPXV) Vaccination Protects Macaques from Monkeypox

Posts navigation

Older posts
Newer posts
Sign up for Email Alerts
  • Compliance
  • Privacy Policy
  • Terms of Service
  • Site Map

© 2026 Tonix Pharmaceuticals Holding Corp.

imunify-bot-check